Product
|
Company
|
Boston Children's Inventor
|
Clinical Phase
|
| Pomalidomide (multiple indications)
|
Celgene
|
Robert D'Amato, MD, PhD
|
Phase III
|
| Revlimid (various cancer indications)
|
Celgene
|
Robert D'Amato, MD, PhD
|
Phase III
|
| Von Willebrand Factor
|
Baxter
|
Stuart Orkin, MD
|
Phase III
|
| FcRn-Factor VIII and Factor IX
|
Biogen IDEC
|
Wayne Lencer, MD
|
Phase III
|
| Omegaven (Parenteral Nutrition Associated Liver Disease)
|
Fresenius Kabi
|
Mark Puder, MD, PhD
|
Phase II/III
|
| Neo-Urinary Conduit(TM)
|
Tengion
|
Anthony Atala, MD
|
Phase I
|
| dmPGE2
|
Fate Therapeutics
|
Leonard Zon, MD
|
Phase II
|
| IgF-I
|
Premacure
|
Lois Smith, MD, PhD
|
Phase II
|
| Autism Gene Expression Diagnostic
|
SynapDX
|
Louis Kunkel, PhD and Issac Kohane, MD, PhD
|
Phase I
|